Demographics of Study Cohort (n = 38)
Characteristic | Parameter | n | % |
---|---|---|---|
Total | 38 | 100 | |
Sex | Male | 15 | 39 |
Female | 23 | 61 | |
Age (y) | Median | 66 | |
Range | 28–81 | ||
Primary site | Lung | 38 | 100 |
Grade for bronchial NEN | Typical carcinoid | 9 | 24 |
Atypical carcinoid | 22 | 58 | |
LCNEC | 3 | 8 | |
SCNEC | 1 | 3 | |
Unknown* | 3 | 8 | |
Mitotic count | Median | 3.5 | |
Range | 0–50 | ||
Ki-67 index | Median | 15 | |
Range | 1–80 | ||
Necrosis | Yes | 16 | 42 |
No | 11 | 29 | |
Unknown | 11 | 39 | |
Site of metastasis | Lungs | 19 | 50 |
Lymph nodes | 19 | 50 | |
Liver | 21 | 55 | |
Bone | 23 | 61 | |
Brain | 4 | 11 | |
Other† | 11 | 32 | |
Extrahepatic disease | Yes | 36 | 95 |
No | 2 | 5 | |
Received PRRT | Yes | 19 | 50 |
No | 19 | 50 |
↵* Of these 3 cases, 2 were well-differentiated NEN without specific comment on histologic report as to whether this represented typical or atypical carcinoid. One was mixed high-grade and low-grade NEN.
↵† Other sites of disease included peritoneum (4 patients), pancreas (3 patients), adrenal glands (2 patients), pericardium (1 patient), and ovary (1 patient).
LCNEC = large cell neuroendocrine carcinoma; SCNEC = small cell neuroendocrine carcinoma.